NCT04893031View on ClinicalTrials.gov

Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study

CompletedOBSERVATIONAL

Enrollment

213

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

March 1, 2021

Study Completion Date

April 1, 2021

Conditions

TocilizumabCOVID-19Critical CareMortality

Interventions

DRUG

Tocilizumab

400mg or 800 mg IV tocilizumab treatment according to patient clinical severity

Trial Locations (1)

61080

Karadeniz Technical University, Trabzon

All Listed Sponsors

lead

Karadeniz Technical University

OTHER

NCT04893031 - Effect of Tocilizumab on Intensive Care Patients With COVID-19 Pneumonia, a Retrospective Cohort Study | Biotech Hunter | Biotech Hunter